These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8532144

  • 1. Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions.
    McCauley PG, O'Boyle KM, Waddington JL.
    Neuropharmacology; 1995 Jul; 34(7):777-83. PubMed ID: 8532144
    [Abstract] [Full Text] [Related]

  • 2. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB, Lawlor M, Dunne A, O'Boyle KM.
    J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
    [Abstract] [Full Text] [Related]

  • 3. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 4. In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist binding.
    De Keyser J, Walraevens H, Ebinger G, Vauquelin G.
    J Neurochem; 1989 Oct; 53(4):1096-102. PubMed ID: 2527968
    [Abstract] [Full Text] [Related]

  • 5. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 6. Altered dopamine receptor mediated signal transmission in the striatum of aged rats.
    May T, Sugawa M.
    Brain Res; 1993 Feb 26; 604(1-2):106-11. PubMed ID: 8457839
    [Abstract] [Full Text] [Related]

  • 7. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec 26; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 8. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB, O'Boyle KM.
    Eur J Pharmacol; 1994 Jun 15; 268(1):79-88. PubMed ID: 7925614
    [Abstract] [Full Text] [Related]

  • 9. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ, Battaglia G, Norman AB, Iorio LC, Creese I.
    Eur J Pharmacol; 1986 Feb 11; 121(1):31-8. PubMed ID: 2869957
    [Abstract] [Full Text] [Related]

  • 10. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 11; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 11. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.
    Graham WC, Sambrook MA, Crossman AR.
    Brain Res; 1993 Feb 05; 602(2):290-303. PubMed ID: 8095431
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Repeated quinpirole treatments produce neurochemical sensitization and associated behavioral changes in female hamsters.
    Chester JA, Mullins AJ, Nguyen CH, Watts VJ, Meisel RL.
    Psychopharmacology (Berl); 2006 Sep 07; 188(1):53-62. PubMed ID: 16850118
    [Abstract] [Full Text] [Related]

  • 17. D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens.
    Keys AS, Mark GP.
    Neuroscience; 1998 Sep 07; 86(2):521-31. PubMed ID: 9881866
    [Abstract] [Full Text] [Related]

  • 18. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 07; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 19. D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis).
    Madras BK, Fahey MA, Canfield DR, Spealman RD.
    J Neurochem; 1988 Sep 07; 51(3):934-43. PubMed ID: 2970527
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.
    Grondin R, Goulet M, Morissette M, Bédard PJ, Di Paolo T.
    Eur J Pharmacol; 1999 Aug 13; 378(3):259-63. PubMed ID: 10493101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.